Five sessions and counting: Considering ultra-brief treatment for panic disorder

Depression and Anxiety

Volumn 29, Issue 6, 2012, Pages 465-470

  Otto, Michael W ^a   Tolin, David F ^b   Nations, Kari R ^c   Utschig, Angela C ^a   Rothbaum, Barbara O ^d   Hofmann, Stefan G ^a   Smits, Jasper A J ^e  

^a BOSTON UNIVERSITY   (United States)

^b INSTITUTE OF LIVING   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d EMORY UNIVERSITY   (United States)

^e SOUTHERN METHODIST UNIVERSITY   (United States)

Author keywords

brief treatment; CBT; cognitive behavioral therapy; interoceptive exposure; panic disorder

Indexed keywords

ANTIPANIC AGENT; CYCLOSERINE; ORG 25935; UNCLASSIFIED DRUG;

CLINICAL EFFECTIVENESS; COGNITIVE THERAPY; FOLLOW UP; HEALTH CARE COST; HUMAN; OUTCOME ASSESSMENT; PANIC; PRIORITY JOURNAL; RESOURCE ALLOCATION; REVIEW; SINGLE DRUG DOSE; TREATMENT DURATION; TREATMENT RESPONSE;

COGNITIVE THERAPY; HUMANS; PANIC DISORDER; PSYCHOTHERAPY, BRIEF; TREATMENT OUTCOME;

EID: 84862744010     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.21910     Document Type: Review

References (50)

1. Candilis PJ, McLean RYS, Otto MW, Manfro GG, Worthington JJ, Penava SJ, Pollack MH,. Quality of life in patients with panic disorder. J Nerv Ment Dis 1999; 187: 429-434. (Pubitemid 29342958)
2. Carpiniello B, Baita A, Carta MG, Sitzia R, Macciardi AM, Murgia S, Altamura AC,. Clinical and psychosocial outcome of patients affected by panic disorder with or without agoraphobia: results from a naturalistic follow-up study. Eur Psychiatry 2002; 17: 394-398. (Pubitemid 35429273)
3. Heldt E, Blaya C, Kipper L, Junior GS, Otto MW, Manfro GG,. Defense mechanisms after brief cognitive-behavior group therapy for panic disorder: 1-year follow-up. J Nerv Ment Dis 2007; 195: 540-543. (Pubitemid 46945495)
4. Katzelnick DJ, Kobak KA, DeLeire T, Henk HJ, Greist JH, Davidson JR,. Impact of generalized panic disorder in managed care. Am J Psychiatry 2001; 158: 1999-2007. (Pubitemid 33104105)
5. Leon AC, Portera L, Weissman MM,. The social costs of anxiety disorders. Br J Psychiatry 1995; 27: 19-22.
6. Schneider S, Houweling JE, Gommlich-Schneider S, Klein C, Nündel B, Wolke D,. Effect of maternal panic disorder on mother-child interaction and relation to child anxiety and child self-efficacy. Arch Women Ment Health 2009; 12: 251-259.
7. Zaider TI, Heimberg RG, Lida M,. Anxiety disorders and intimate relationships: a study of daily processes in couples. J Abnorm Psychol 2010; 119: 163-173.
8. World Health Organization. The world health report 2001. Mental Health: New Understanding, New Hope. Geneva: World Health Organization; 2001.
9. Leon AC, Olfson M, Portera L,. Service utilization and expenditures for the treatment of panic disorder. Gen Hos Psychiatry 1997; 19: 82-88. (Pubitemid 27146815)
10. McHugh RK, Otto MW, Barlow DH, Gorman JM, Shear MK, Woods SW,. Cost-efficacy of individual and combined treatments of panic disorder. J Clin Psychiatry 2007; 68: 1038-1044. (Pubitemid 47340324)
11. Otto MW, Pollack MH, Maki KM,. Empirically-supported treatment for panic disorder: costs, benefits, and stepped care. J Consult Clin Psychol 2000; 68: 556-563.
12. Otto MW,. The dose and delivery of psychotherapy: a commentary on Hansen et al. Clin Psychol: Sci Prac 2002; 9: 348-349. (Pubitemid 41288886)
13. Hansen, Lambert MJ, Forman EM,. The psychotherapy fose-response effect and its implications for treatment delivery services. Clin Psychol: Sci Prac 2002; 9: 329-343. (Pubitemid 41288884)
14. Smits JA, Powers MB, Cho Y, Telch MJ,. Mechanism of change in cognitive-behavioral treatment of panic disorder: evidence for the fear of fear mediational hypothesis. J Consult Clin Psychol 2004; 72: 646-652. (Pubitemid 38988841)
15. Smits JA, Berry AC, Tart CD, Powers MB,. The efficacy of cognitive-behavioral interventions for reducing anxiety sensitivity: a meta-analytic review. Behav Res Ther 2008; 46: 1047-1054.
16. Gardenswartz C, Craske M,. Prevention of panic disorder. Behav Ther 2001; 32: 725-737. (Pubitemid 34326713)
17. Schmidt NB, Eggleston AM, Wollaway-Bickel K, Fitzpatrick KK, Vasey MW, Richey JA,. Anxiety Sensitivity Amelioration Training (ASAT): a longitudinal primary prevention program targeting cognitive vulnerability. J Anxiety Disord 2007; 21: 302-319. (Pubitemid 46415662)
18. Schmidt NB, Woolaway-Bickel K, Trakowski J, Santiago H, Storey J, Koselka M, Cook J,. Dismantling cognitive-behavioral treatment for panic disorder: questioning the utility of breathing retraining. J Consult Clin Psychol 2000; 68: 417-424.
19. Otto MW, Powers MB, Fischmann D,. Emotional exposure in the treatment of substance use disorders: conceptual model, evidence, and future directions. Clin Psychol Rev 2005; 25: 824-839. (Pubitemid 41021842)
20. Craske MG, Brown TA, Barlow DH,. Behavioral treatment of panic: a two year follow-up. Behav Ther 1991; 22: 289-304.
21. Otto MW, McHugh RK, Simon NM, Farach FJ, Worthington JJ, Pollack MH,. Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: further evaluation. Behav Res Ther 2010; 48: 720-727.
22. Foa EB, Hembree E, Rothbaum BO,. Prolonged Exposure Therapy for PTSD: Emotional Processing of Traumatic Experiences: Therapist Guide. New York: Oxford University Press; 2007.
23. Simon NM, Connor KM, Lang AJ, Rauch S, Krulewicz S, LeBeau RT, Davidson JR, Stein MB, Otto MW, Foa EB, Pollack MH,. Paroxetine-CR augmentation for posttraumatic stress disorder refractory to exposure therapy. J Clin Psychiatry 2008; 69: 400-405. (Pubitemid 351549392)
24. Guastella AJ, Richardson R, Lovibond PF, Rapee RM, Gaston JE, Mitchell P, Dadds MR,. A randomised controlled trial of d-cycloserine enhancement of exposure therapy for social anxiety disorder. Biol Psychiatry 2008; 63: 544-549.
25. Hofmann SG, Meuret AE, Smits JAJ, Simon NM, Pollack MH, Eisenmenger K,. Augmentation of exposure therapy for panic disorder with D-Cycloserine. Arch Gen Psychiatry 2006; 63: 298-304. (Pubitemid 43345354)
26. Otto MW, Tolin DF, Simon NM, Pearlson GD, Basden S, Meunier SA, Hofmann SG, Eisenmenger K, Krystal JH, Pollack MH,. The efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder. Biol Psychiat 2009; 67: 365-370.
27. Ressler KJ, Rothbaum BO, Tannenbaum L, Anderson P, Graap K, Zimand E, et al. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry 2004; 61: 1136-1144. (Pubitemid 39463415)
28. Nations KR, Smits JAJ, Tolin DF, Rothbaum BO, Hofmann SG, Tart CD, Lee A, Schipper J, Sjogren M, Xue D, Otto MW,. (in press). Evaluation of the glycine transporter inhibitor Org25935 as augmentation to cognitive-behavioral therapy in panic disorder. J. Clin. Psychiatry; doi: 10.4088/JCP.11m07081.
29. Clark DM, Salkovskis PM, Hackmann A, Wells A, Ludgate J, Gelder M,. Brief cognitive therapy for panic disorder: a randomized controlled trial. J Consult Clin Psychol 1999; 67: 583-589. (Pubitemid 29379473)
30. Craske MG, Maidenberg E, Bystritsky A,. Brief cognitive-behavioral versus nondirective therapy for panic disorder. J Behav Ther Exp Psychiatry 1995; 26: 113-120.
31. Roy-Byrne PP, Craske MG, Stein MB, Sullivan G, Bystritsky A, Katon W, Golinelli D, Sherbourne CD,. A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder. Arch Gen Psychiatry 2005; 62: 290-298. (Pubitemid 40990974)
32. Deacon B, Abramowitz J,. A pilot study of two-day cognitive-behavioral therapy for panic disorder. Behav Res Ther 2006; 44: 807-817.
33. Otto MW, Pollack MH,. Stopping Anxiety Medication. Therapist Guide. 2nd ed. New York: Oxford University Press; 2009.
34. Heldt E, Manfro GG, Kipper L, Blaya C, Isolan L, Otto MW,. One-year follow-up of pharmacotherapy-resistant patients with panic disorder treated with cognitive-behavior therapy: outcome and predictors of remission. Behav Res Ther 2006; 44: 657-665.
35. Heldt E, Manfro GG, Kipper L, Blaya C, Maltz S, Isolan L, Hirakata VN, Otto MW,. Treating medication-resistant panic disorder: predictors and outcome of cognitive-behavior therapy in a Brazilian public hospital. Psychother Psychosom 2003; 72: 43-48. (Pubitemid 35478111)
36. Penava SJ, Otto MW, Maki KM, Pollack MH,. Rate of improvement during cognitive-behavioral group treatment for panic disorder. Behav Res Ther 1998; 36: 665-673. (Pubitemid 28339787)
37. Whittal ML, Otto MW, Hong JJ,. Cognitive-behavior therapy for discontinuation of SSRI treatment of panic disorder: a case series. Behav Res Ther 2001; 39: 939-945. (Pubitemid 32515195)
38. Barlow DH, Craske MG,. Mastery of Your Anxiety and Panic: Therapist Guide. 2nd ed. New York: Oxford University Press; 2006.
39. Powers MB, Vervliet B, Smits JAJ, Otto MW,. Helping exposure succeed: learning theory perspectives on treatment resistance and relapse. In:, Otto MW, Hofmann SG, editors. Avoiding Treatment Failures in the Anxiety Disorders. New York: Springer; 2010: 31-49.
40. Norton PJ, Price EC,. A meta-analytic review of adult cognitive-behavioral treatment outcome across the anxiety disorders. J Nerv Ment Dis 2007; 195: 521-531. (Pubitemid 46945492)
41. Bakker A, van Balkom AJ, Spinhoven P,. SSRIs vs. TCAs in the treatment of panic disorder: a meta-analysis. Acta Psychiat Scand 2002; 106: 163-167.
42. Barlow DH, Gorman JM, Shear MK, Woods SW,. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial. J Am Med Assoc 2000; 283: 2529-2536. (Pubitemid 30324195)
43. Furukawa TA, Watanabe N, Omori IM, Churchill R,. Can pill placebo augment cognitive-behavior therapy for panic disorder ? BMC Psychiatry 2007; 7: 73.
44. Craske MG, Barlow DH,. Mastery of Your Anxiety and Worry: Therapist Guide. 2nd ed. New York: Oxford University Press; 2006.
45. Hope DA, Heimberg RG, Turk CL,. Managing Social Anxiety: A Cognitive-Behavioral Therapy Approach: Therapist Guide. New York: Oxford University Press; 2006.
46. Otto MW, Simon NM, Olatunji BO, Sung SC, Pollack MH,. 10-Minute CBT: Integrating Cognitive-Behavioral Strategies into Your Practice. New York: Oxford University Press; 2011.
47. Cialdini RB,. Influence: The Psychology of Persuasion. New York: William Morrow and Company, Inc.; 1993.
48. Montgomery RW, Ayllon T,. Matching verbal repertoires: understanding the contingencies of practice in order to functionally communicate with clinicians. J Behav Ther Exp Psychiatry 1995; 26: 99-105.
49. Craske MG, Edlund MJ, Sullivan G, Roy-Byrne P, Sherbourne C, Bystritsky A, Stein MB,. Perceived unmet need for mental health treatment and barriers to care among patients with panic disorder. Psychiatr Serv 2005; 56: 988-994. (Pubitemid 41098739)
50. Therapist-free therapy: cognitive-bias modification may put the psychiatrist's couch out of business. The Economist. London: The Economist Newspaper Limited.